审计神经技术进步对健康公平的影响

G. Wolbring
{"title":"审计神经技术进步对健康公平的影响","authors":"G. Wolbring","doi":"10.14740/JNR.V0I0.695","DOIUrl":null,"url":null,"abstract":"Health equity understood as the ability to live a healthy life, to have a good life, is impacted by many social determinants and by the social marginalization of various groups. “Measures” that use indicators to cover social determinants of a good life are useful tools to audit the impact of neuro-advancements on health equity. In this scoping review, I covered over 50 neurotechnologies, neuroenhancement, artificial intelligence (AI) machine learning (ML), robotics, neuroethics, neuro-governance and neurotechnology governance and various “measures” that focus on the ability to have a good life to answer three research questions: 1) Are the “measures” engaged with in the academic literature covering health equity or the chosen technologies? 2) Does the academic literature focusing on the technologies covered, neuroethics, or neurotechnology governance engage with health equity? 3) To what extent does the academic literature focusing on the technologies covered engage with the different primary and secondary indicators of four of the “measures” (social determinants of health, Better Life Index, Canadian Index of Well-Being, and community-based rehabilitation matrix)? For the scoping review, I examined the academic literature present in SCOPUS, which includes all Medline articles, and the 70 databases accessible under EBSCO-HOST and I employed a quantitative hit count approach for the analysis. I found that the term “health equity” was only mentioned in conjunction with the terms “determinants of health” and “social determinants of health” in a substantial way. Three of the terms linked to the “measures” were each mentioned in less than 10 abstracts and 16 terms linked to the “measures” were not mentioned at all in conjunction with the term “health equity”. Health equity was also rarely to not at all mentioned in conjunction with the different technologies covered and not at all in conjunction with the terms “neuroethics”, “neurotechnology governance” or “neuro-governance”. Finally, there was uneven engagement with the primary and secondary indicators of the four chosen “measures” in conjunction with the technologies covered. The results reveal vast opportunities at the intersections of neuroethics and neuro-governance and science and technology governance in general, health equity, social justice, and wellbeing discourses. J Neurol Res. 2021;000(000):000-000 doi: https://doi.org/10.14740/jnr695","PeriodicalId":16489,"journal":{"name":"Journal of Neurology Research","volume":"223 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Auditing the Impact of Neuro-Advancements on Health Equity\",\"authors\":\"G. Wolbring\",\"doi\":\"10.14740/JNR.V0I0.695\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Health equity understood as the ability to live a healthy life, to have a good life, is impacted by many social determinants and by the social marginalization of various groups. “Measures” that use indicators to cover social determinants of a good life are useful tools to audit the impact of neuro-advancements on health equity. In this scoping review, I covered over 50 neurotechnologies, neuroenhancement, artificial intelligence (AI) machine learning (ML), robotics, neuroethics, neuro-governance and neurotechnology governance and various “measures” that focus on the ability to have a good life to answer three research questions: 1) Are the “measures” engaged with in the academic literature covering health equity or the chosen technologies? 2) Does the academic literature focusing on the technologies covered, neuroethics, or neurotechnology governance engage with health equity? 3) To what extent does the academic literature focusing on the technologies covered engage with the different primary and secondary indicators of four of the “measures” (social determinants of health, Better Life Index, Canadian Index of Well-Being, and community-based rehabilitation matrix)? For the scoping review, I examined the academic literature present in SCOPUS, which includes all Medline articles, and the 70 databases accessible under EBSCO-HOST and I employed a quantitative hit count approach for the analysis. I found that the term “health equity” was only mentioned in conjunction with the terms “determinants of health” and “social determinants of health” in a substantial way. Three of the terms linked to the “measures” were each mentioned in less than 10 abstracts and 16 terms linked to the “measures” were not mentioned at all in conjunction with the term “health equity”. Health equity was also rarely to not at all mentioned in conjunction with the different technologies covered and not at all in conjunction with the terms “neuroethics”, “neurotechnology governance” or “neuro-governance”. Finally, there was uneven engagement with the primary and secondary indicators of the four chosen “measures” in conjunction with the technologies covered. The results reveal vast opportunities at the intersections of neuroethics and neuro-governance and science and technology governance in general, health equity, social justice, and wellbeing discourses. J Neurol Res. 2021;000(000):000-000 doi: https://doi.org/10.14740/jnr695\",\"PeriodicalId\":16489,\"journal\":{\"name\":\"Journal of Neurology Research\",\"volume\":\"223 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Neurology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14740/JNR.V0I0.695\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/JNR.V0I0.695","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

摘要

健康公平被理解为过上健康生活和美好生活的能力,受到许多社会决定因素和各种群体的社会边缘化的影响。利用指标涵盖良好生活的社会决定因素的“措施”是审计神经科学进步对卫生公平影响的有用工具。在这篇范围审查中,我涵盖了50多种神经技术,神经增强,人工智能(AI)机器学习(ML),机器人技术,神经伦理学,神经治理和神经技术治理以及各种“措施”,这些措施专注于拥有美好生活的能力,以回答三个研究问题:1)“措施”是否涉及涉及健康公平或所选技术的学术文献?2)专注于所涵盖的技术、神经伦理学或神经技术治理的学术文献是否涉及健康公平?3)关注所涵盖技术的学术文献在多大程度上涉及四项“措施”(健康的社会决定因素、更美好生活指数、加拿大福祉指数和社区康复矩阵)的不同主要和次要指标?对于范围审查,我检查了SCOPUS中的学术文献,其中包括所有Medline文章,以及EBSCO-HOST下可访问的70个数据库,我采用了定量命中计数方法进行分析。我发现,“卫生公平”一词只与“健康的决定因素”和“健康的社会决定因素”一词一起被大量提及。与"措施"有关的三个术语在不到10个摘要中分别被提及,与"措施"有关的16个术语根本没有与"卫生公平"一词一起被提及。卫生公平也很少与所涉及的不同技术一起被提及,也很少与“神经伦理学”、“神经技术治理”或“神经治理”等术语一起被提及。最后,在所选的四种“措施”的主要和次要指标与所涵盖的技术的结合方面存在不均衡。研究结果显示,在神经伦理学、神经治理和科学技术治理、健康公平、社会正义和福祉话语的交叉点上,存在着巨大的机会。J Neurol Res. 2021;000(000):000-000 doi: https://doi.org/10.14740/jnr695
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Auditing the Impact of Neuro-Advancements on Health Equity
Health equity understood as the ability to live a healthy life, to have a good life, is impacted by many social determinants and by the social marginalization of various groups. “Measures” that use indicators to cover social determinants of a good life are useful tools to audit the impact of neuro-advancements on health equity. In this scoping review, I covered over 50 neurotechnologies, neuroenhancement, artificial intelligence (AI) machine learning (ML), robotics, neuroethics, neuro-governance and neurotechnology governance and various “measures” that focus on the ability to have a good life to answer three research questions: 1) Are the “measures” engaged with in the academic literature covering health equity or the chosen technologies? 2) Does the academic literature focusing on the technologies covered, neuroethics, or neurotechnology governance engage with health equity? 3) To what extent does the academic literature focusing on the technologies covered engage with the different primary and secondary indicators of four of the “measures” (social determinants of health, Better Life Index, Canadian Index of Well-Being, and community-based rehabilitation matrix)? For the scoping review, I examined the academic literature present in SCOPUS, which includes all Medline articles, and the 70 databases accessible under EBSCO-HOST and I employed a quantitative hit count approach for the analysis. I found that the term “health equity” was only mentioned in conjunction with the terms “determinants of health” and “social determinants of health” in a substantial way. Three of the terms linked to the “measures” were each mentioned in less than 10 abstracts and 16 terms linked to the “measures” were not mentioned at all in conjunction with the term “health equity”. Health equity was also rarely to not at all mentioned in conjunction with the different technologies covered and not at all in conjunction with the terms “neuroethics”, “neurotechnology governance” or “neuro-governance”. Finally, there was uneven engagement with the primary and secondary indicators of the four chosen “measures” in conjunction with the technologies covered. The results reveal vast opportunities at the intersections of neuroethics and neuro-governance and science and technology governance in general, health equity, social justice, and wellbeing discourses. J Neurol Res. 2021;000(000):000-000 doi: https://doi.org/10.14740/jnr695
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Non-Invasive Neuromodulation for Episodic and Chronic Migraine Headache: Preliminary Findings on Feasibility of At-Home Transcranial Direct Current Stimulation With Remote Supervision Effectiveness of Relaxation and Respiratory Exercise on Sleep Quality, Depression and Spasticity in Hemiplegic Stroke Patients: Preliminary Findings Neuro-Abilities and a Good Life Small Number of Coils With Extended Length in the Endovascular Treatment of Cerebral Aneurysm: Experience of 108 Cases in a Single-Center Motor Neuron Disease-Frontotemporal Dementia Spectrum Disorder: A Different Phenotype Related With a Novel TBK1 Gene Variant
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1